CSF1R and neoplasm: TAMs can interfere with therapeutic outcomes by modulating interactions between tumor and stromal cells.257 Leila Akkari et al. reported an increase in total TAM populations in glioblastoma-bearing mice treated with ionizing radiation (IR), which was inhibited by the CSF-1R tyrosine kinase inhibitor BLZ945.